![Corey Goodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corey Goodman
Gründer bei
Tallac Therapeutics, Inc.
Vermögen: 346 456 $ am 30.06.2026
Profil
Corey S.
Goodman founded Exelixis, Inc. in 1994, Second Genome, Inc. in 2009, Labrys Biologics, Inc. in 2012, where he worked as Chairman from 2012 to 2014, and various other companies.
Dr. Goodman also founded The Helen Wills Neuroscience Institute and Tallac Therapeutics, Inc., where he is working as Chairman.
Dr. Goodman also currently works at Bay Area Science & Innovation Consortium, as Director, Emaldi Corp., as Director, Attralus, Inc., as Director, and various other companies.
Dr. Goodman also formerly worked at Solstice Biologics LLC, as Executive Chairman, President & CEO from 2013 to 2014, The Bay Area Bioscience Association, as Vice Chairman, The National Research Council, as Chairman, and various other companies.
Dr. Goodman received his undergraduate degree from Stanford University and doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 167 370 ( 0,12 % ) | 346 456 $ | 30.06.2026 |
Aktive Positionen von Corey Goodman
| Unternehmen | Position | Beginn |
|---|---|---|
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
American Philosophical Society
 American Philosophical Society Miscellaneous Commercial ServicesCommercial Services Operates scholarly organization that promotes knowledge in the sciences and humanities | Corporate Officer/Principal | - |
The California Council on Science & Technology
 The California Council on Science & Technology Miscellaneous Commercial ServicesCommercial Services Provides objective advice of scientists and research institutions on policy issues involving science | Corporate Officer/Principal | - |
Bay Area Science & Innovation Consortium | Direktor/Vorstandsmitglied | - |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Gründer | 01.06.2009 |
Emaldi Corp. | Direktor/Vorstandsmitglied | - |
Goodman Barinaga Trust | Direktor/Vorstandsmitglied | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Gründer | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Corey Goodman
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Corey Goodman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
35
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 35 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Develops cell-permeable RNAi pro-drugs | Health Technology |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
American Philosophical Society
American Philosophical Society Miscellaneous Commercial ServicesCommercial Services Operates scholarly organization that promotes knowledge in the sciences and humanities | Commercial Services |
The California Council on Science & Technology
The California Council on Science & Technology Miscellaneous Commercial ServicesCommercial Services Provides objective advice of scientists and research institutions on policy issues involving science | Commercial Services |
The Bay Area Bioscience Association
 The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
The McKnight Endowment Fund for Neuroscience
 The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous Operates a charitable organization that works to bring science closer to the diseases of the brain and behaviour can be diagnosed, prevented and treated | Miscellaneous |
Limerick BioPharma, Inc.
 Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy consulting and advice | Commercial Services |
Bay Area Science & Innovation Consortium | |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Finance |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Develops single domain antibodies | Health Technology |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
The Helen Wills Neuroscience Institute | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Emaldi Corp. | |
Goodman Barinaga Trust | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Axonis Therapeutics, Inc.
 Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for neurological disorders | Health Services |
